Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.69	22.26	30.56	19.78	1.75
Short-Term Investments	71.82	44.55	57.04	64	-
Cash & Short-Term Investments	106.51	66.81	87.6	83.79	1.75
Cash Growth	59.42%	-23.73%	4.55%	4675.54%	-13.44%
Accounts Receivable	0.1	0.09	0.1	0.1	-
Inventory	0.31	0.17	0.15	0.28	-
Other Current Assets	0.99	2.09	1.27	0.53	0.05
Total Current Assets	107.91	69.17	89.11	84.69	1.8
Net Property, Plant & Equipment	3.21	3.49	2.83	3.68	-
Long-Term Investments	2.5	2.5	2.5	2.5	160.02
Other Long-Term Assets	1.24	1.02	0.77	4.71	-
Total Assets	114.86	76.17	95.21	95.57	161.82
Accounts Payable	6.1	5.13	2.9	3.97	0
Accrued Expenses	9.89	6.08	5.15	5.38	0.16
Current Portion of Leases	0.75	0.55	0.65	0.7	-
Unearned Revenue	-	4.44	2.51	6.44	-
Other Current Liabilities	-	-	-	2.09	-
Total Current Liabilities	16.74	16.21	11.21	18.57	0.17
Long-Term Debt	30.75	14.29	-	9.49	-
Long-Term Leases	0.94	1.69	1.04	1.68	-
Other Long-Term Liabilities	3.06	11.03	14.92	13.3	5.6
Total Long-Term Liabilities	34.74	27.01	15.96	24.47	5.6
Total Liabilities	51.48	43.22	27.17	43.04	5.77
Preferred Stock	9.81	-	-	-	-
Common Stock	0.01	0	0	0	0
Additional Paid-in Capital	416.08	342.78	316.9	252.27	-
Accumulated Other Comprehensive Income	0.06	0.05	-0.01	-0.01	-
Retained Earnings	-362.58	-309.88	-248.85	-199.73	-3.94
Total Common Shareholders' Equity	63.38	32.96	68.04	52.53	-3.94
Minority Interest	-	-	-	-	160
Shareholders' Equity	63.38	32.96	68.04	52.53	156.06
Total Liabilities & Equity	114.86	76.17	95.21	95.57	161.82
Total Debt	32.44	16.53	1.69	11.87	0
Net Cash (Debt)	74.08	50.28	85.91	71.92	1.75
Net Cash Growth	47.32%	-41.47%	19.46%	3998.98%	-13.44%
Net Cash Per Share	1.55	1.37	2.59	4.80	0.20
Book Value	63.38	32.96	68.04	52.53	-3.94
Book Value Per Share	1.33	0.90	2.05	3.50	-0.45
Tangible Book Value	63.38	32.96	68.04	52.53	-3.94
Tangible Book Value Per Share	1.33	0.90	2.05	3.50	-0.45

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q